Cubist Systematic Strategies’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-93,669
| Closed | -$352K | – | 2099 |
|
|
2025
Q1 | $352K | Buy |
93,669
+67,682
| +260% | +$254K | ﹤0.01% | 1092 |
|
|
2024
Q4 | $152K | Buy |
+25,987
| New | +$152K | ﹤0.01% | 1227 |
|
|
2024
Q3 | – | Sell |
-13,416
| Closed | -$145K | – | 2034 |
|
|
2024
Q2 | $145K | Buy |
+13,416
| New | +$145K | ﹤0.01% | 1129 |
|
|
2023
Q2 | – | Sell |
-15,161
| Closed | -$52.6K | – | 2795 |
|
|
2023
Q1 | $52.6K | Buy |
15,161
+1,041
| +7% | +$3.61K | ﹤0.01% | 2518 |
|
|
2022
Q4 | $34.6K | Sell |
14,120
-23,194
| -62% | -$56.8K | ﹤0.01% | 2987 |
|
|
2022
Q3 | $103K | Sell |
37,314
-31,421
| -46% | -$86.7K | ﹤0.01% | 3214 |
|
|
2022
Q2 | $280K | Sell |
68,735
-25,555
| -27% | -$104K | ﹤0.01% | 2975 |
|
|
2022
Q1 | $402K | Buy |
94,290
+9,092
| +11% | +$38.8K | ﹤0.01% | 2647 |
|
|
2021
Q4 | $797K | Buy |
85,198
+43,366
| +104% | +$406K | 0.01% | 2099 |
|
|
2021
Q3 | $1.15M | Buy |
41,832
+39,682
| +1,846% | +$1.09M | 0.01% | 1411 |
|
|
2021
Q2 | $60K | Buy |
+2,150
| New | +$60K | ﹤0.01% | 2772 |
|